Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Interview of the week

UK care sector draws strong interest from global private equity

2025 was a busy year for the care sector, with lots of M&A deals either happening, planned, or being considered. Activity has risen sharply and the market is currently at a high point. HBI spoke with Amar Shah, Partner, and Vikas Sharma, Director, both in Healthcare and Life Sciences M&A at Deloitte UK, about trends in the UK social care market, including investment flows, valuations, staffing, technology and expectations for 2026.

Growth equity investors are driving recovery in European healthcare M&A 

The private equity sector has faced a difficult environment for dealmaking over the past two and a half years, due to higher interest rates, regulatory uncertainty and global political pressures. This has led to a slowdown in M&A deal activity in healthcare, as well as other sectors. There are now signs of recovery. Europe is attracting more interest from global investors, especially those seeking high-quality assets with strong growth potential.

How digital tools are transforming rehabilitation — Interview with Philipp Schulte-Noelle, CEO, MEDIAN Group

In a conversation with HBI, the CEO of MEDIAN Group, Philipp Schulte-Noelle, talks about rehabilitation in Germany and Europe, the role of digital and AI in mental health, and investor interest in the sector.

Interview: Andrew Neville, Inflexion

Inflexion is a European mid-market private equity firm that invests in multiple healthcare sub sectors — medical devices, outsourced pharma services, specialty pharma products and animal health. In a conversation with HBI, Andrew Neville, Partner, explained what Inflexion is looking for in the businesses it invests in, and offers case studies of two companies currently in its portfolio.

Interview: Ranjan Singh, CEO and Co-founder, HealthHero

HealthHero is the largest telehealth provider in Europe. In the few years since being founded in 2019, it has managed to consistently grow its revenue at over 30% per annum and achieve a dominant position in four key European markets — the UK, France, Germany and Ireland, in a period when many other players trying to scale in this space have gone bust.

What Eko Health’s AI stethoscope can teach us about AI adoption in healthcare

An AI-powered digital stethoscope developed by a California-based medtech company called Eko Health has been found to detect heart conditions with significantly greater sensitivity than doctors using analogue stethoscopes in a trial with 200 UK GP practices. But the same study also found that 70% of these GP surgeries had stopped using them or were only using them infrequently a year after they were given them. In a conversation with HBI, Alfred Olivares and Nick Kovacev, who work for US technology consultancy HTEC, suggested some of the reasons for this, and the broader lessons for health tech companies trying to develop impactful AI tools.

Interview with Dr. Rahul Goyal (Elsevier) on AI’s impact in healthcare

Elsevier, a publishing house and provider of information and decision support tools for science and healthcare, recently published its Clinician of the Future 2025 annual insights report, which looks at the growing use of AI in healthcare and how healthcare professionals feel about it. We spoke to Dr. Rahul Goyal, Elsevier’s Practicing GP and Clinical Executive, to get his thoughts on what impact AI is having and what investors, operators and regulators need to be mindful of.

Investing in Europe’s healthcare energy transition – interview with Andrey Maramzine, Chief Sustainability Officer, BNP Paribas Leasing Solutions

BNP Paribas Leasing Solutions, a fully owned subsidiary of the BNP Paribas Group, France-based second largest bank in Europe, offers green finance for hospital decarbonisation through sustainability-linked loans, green bonds, and leasing. In 2024, the bank arranged a €1.45 billion sustainability-linked loan for Ramsay Santé. It also invests in nearly 80 ESG-focused healthcare properties. HBI spoke with Maramzine to learn more about the PaaS model and explore the investment opportunities in Europe’s green healthcare infrastructure.

Interview with Maximilian Peschel (Silver Mountain Capital and Artemed SE) on hospital privatisations in China

Maximilian Peschel has been based in China since April 2025, working for Chinese healthcare investment firm Silver Mountain Group and German hospital group Artemed SE on a hospital privatisation project in Chongqing. In an interview with HBI, he discussed the project, and the challenges and opportunities for foreign investors looking to enter China’s hospital sector.

Interview with Ash Ramachandran, Founder of Sapyen, on the untapped male fertility diagnostics market

Sapyen, an online male fertility diagnostics company based in Melbourne, with operations across the UK, Europe, the US, and Australia, is trying to fix that. The company has developed a home testing kit that extends the viability of semen samples, making it easier for men to get tested without needing to visit a clinic. Ash Ramachandran, the founder of Sapyen, spoke to HBI about the fertility landscape, investment trends, and how the company is helping men access testing more easily.

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us